COVID-19 increases risk of long-term brain problems
In a study from Washington University in St. Louis and elsewhere, scientists found those who have been infected with the virus are at increased...
Scientists find how COVID-19 damages the heart
In a study from the University of Queensland, scientists have discovered how COVID-19 damages the heart, opening the door to future treatments.
This initial study...
Depression, loneliness linked to higher hospitalization risk after COVID-19
In a study from Harvard University, scientists found people who reported in a survey that they felt worried, depressed, or lonely had a greater...
Saliva test could show early warning for severe COVID-19
In a study from the University of Surrey, scientists found saliva samples could soon be key to predicting the severity of someone's case of...
COVID vaccination could affect menstrual cycle in women
In a study from Oregon Health & Science University, scientists found some people may experience a slight, temporary change in the length of their...
New blood test could predict who is likely to get long COVID
In a study from UCL, scientists found a blood test taken at the time of COVID-19 infection could predict who is most likely to...
People hospitalized with COVID-19 may have higher risk of heart failure
In a study from Duke University, scientists found people hospitalized for COVID-19 were more likely to have heart failure after their discharge than those...
COVID-19 virus can infect fat tissue, shows Stanford study
The findings could explain why obese people have a higher risk of SARS-CoV-2 infection and are more likely to progress to severe disease and...
What to know about the new COVID booster
Epidemiologist and Professor Amira Roess answers frequently asked questions about the newest COVID booster shot.
In the United States, a new COVID-19 booster shot has...
Scientists confirm a drug for treating mild-to-moderate COVID-19 effectively
In a study from Mayo Clinic, scientists found that for high-risk patients with mild-to-moderate COVID-19 during the Omicron epoch, bebtelovimab seems to be a...